{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:13:56Z","timestamp":1787066036247,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tvr.2026.200339","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:32:14Z","timestamp":1770312734000},"page":"200339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Chuanyun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chichao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Kay Sheung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9772-2971","authenticated-orcid":false,"given":"Siaw Shi","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.tvr.2026.200339_bib1","first-page":"45","article-title":"Human papilloma virus (HPV) infections related to cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma of the uterine cervix","volume":"17","author":"Syrj\u00e4nen","year":"1985","journal-title":"Ann. Clin. Res."},{"issue":"6","key":"10.1016\/j.tvr.2026.200339_bib2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"1990","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.tvr.2026.200339_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/OP.22.00156","article-title":"Cervical cancer in Low- and middle-income countries: a multidimensional approach to closing the gaps","volume":"18","author":"Mullapally","year":"2022","journal-title":"JCO Oncol. Pract."},{"issue":"S10","key":"10.1016\/j.tvr.2026.200339_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.tvr.2026.200339_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106335","article-title":"National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects","author":"Tsu","year":"2021","journal-title":"Prev. Med.: Int. J. Devoted Pract. Theory"},{"key":"10.1016\/j.tvr.2026.200339_bib7","series-title":"Global Burden of Cancer Attributable to Infections in 2018: a Worldwide Incidence Analysis","author":"de Martel C","year":"2020"},{"issue":"4","key":"10.1016\/j.tvr.2026.200339_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006211","article-title":"The role of integration in oncogenic progression of HPV-associated cancers","volume":"13","author":"Mcbride","year":"2017","journal-title":"PLoS Pathog."},{"issue":"4951","key":"10.1016\/j.tvr.2026.200339_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.tvr.2026.200339_bib10","series-title":"The State of the p53 and Retinoblastoma Genesin Human Cervical Carcinoma Cell Lines","first-page":"5523","author":"Howley","year":"1991"},{"issue":"7587","key":"10.1016\/j.tvr.2026.200339_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature16481","article-title":"Structure of the E6\/E6AP\/p53 complex required for HPV-mediated degradation of p53","volume":"529","author":"Martinez-Zapien","year":"2016","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.tvr.2026.200339_bib12","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1128\/JVI.75.16.7583-7591.2001","article-title":"Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7","volume":"75","author":"Gonzalez","year":"2001","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.tvr.2026.200339_bib13","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1128\/JVI.75.15.6737-6747.2001","article-title":"Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes","volume":"75","author":"Helt","year":"2001","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.tvr.2026.200339_bib14","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1128\/jvi.66.12.6893-6902.1992","article-title":"Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins","volume":"66","author":"Dyson","year":"1992","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.tvr.2026.200339_bib15","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/MCB.15.8.4215","article-title":"Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1\/S-regulatory genes","volume":"15","author":"Degregori","year":"1995","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.tvr.2026.200339_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.virol.2008.02.025","article-title":"HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function","volume":"375","author":"Liu","year":"2008","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.tvr.2026.200339_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000605","article-title":"Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation","volume":"5","author":"Moody","year":"2009","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.tvr.2026.200339_bib18","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/JVI.02269-14","article-title":"Role of Cdk1 in the p53-Independent abrogation of the postmitotic checkpoint by human papillomavirus E6","volume":"89","author":"Zhang","year":"2015","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.tvr.2026.200339_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/JVI.72.2.975-985.1998","article-title":"Disruption of the G1\/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E","volume":"72","author":"Martin Lg","year":"1998","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.tvr.2026.200339_bib20","first-page":"7075","article-title":"The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability","volume":"62","author":"Duensing","year":"2003","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.tvr.2026.200339_bib21","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-03-0565","article-title":"DNA aneuploidy and integration of human papillomavirus type 16 E6\/E7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix Uteri","volume":"10","author":"Melsheimer","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.tvr.2026.200339_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.tibs.2005.09.005","article-title":"Mammalian cyclin-dependent kinases","volume":"30","author":"Malumbres","year":"2005","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.tvr.2026.200339_bib23","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1021\/acs.jmedchem.3c00566","article-title":"Novel medicinal chemistry strategies targeting CDK5 for drug discovery","volume":"66","author":"Tang","year":"2023","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.tvr.2026.200339_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/cancers13010101","article-title":"The role of CDK5 in tumours and tumour microenvironments","volume":"13","author":"Do","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tvr.2026.200339_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-017-0611-1","article-title":"Cdk5 links with DNA damage response and cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"38","key":"10.1016\/j.tvr.2026.200339_bib26","doi-asserted-by":"crossref","first-page":"33141","DOI":"10.1074\/jbc.M111.252080","article-title":"Regulation of androgen receptor and prostate cancer growth by cyclin-dependent kinase 5","volume":"286","author":"Hsu","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.tvr.2026.200339_bib27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.trecan.2016.09.001","article-title":"The emerging role of Cdk5 in cancer","volume":"2","author":"Pozo","year":"2016","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.tvr.2026.200339_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12935-023-03112-4","article-title":"CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling","volume":"23","author":"Cao","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.tvr.2026.200339_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-9-204","article-title":"Cdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest\/apoptosis and inhibits tumor progression","volume":"9","author":"Ajay","year":"2010","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.tvr.2026.200339_bib30","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1093\/nar\/gkg584","article-title":"Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs","author":"Obenauer","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.tvr.2026.200339_bib31","article-title":"E6-Encoded by cancer-causing human papillomavirus interacts with Aurora kinase A to promote HPV-mediated carcinogenesis","volume":"97","author":"Li S","year":"2023","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.tvr.2026.200339_bib32","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1242\/jcs.03468","article-title":"Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death","volume":"120","author":"Lee","year":"2007","journal-title":"J. Cell Sci."},{"issue":"14","key":"10.1016\/j.tvr.2026.200339_bib33","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1128\/JVI.74.14.6408-6417.2000","article-title":"Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase","volume":"74","author":"Kao","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2026.200339_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tvr.2026.200339_bib35","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.tvr.2026.200339_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00018-023-04941-2","article-title":"The ubiquitin specific protease 7 stabilizes HPV16E7 to promote HPV-mediated carcinogenesis","volume":"80","author":"Xia","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tvr.2026.200339_bib37","first-page":"187","volume":"2213","author":"Huang","year":"2021"},{"key":"10.1016\/j.tvr.2026.200339_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-62703-444-9_10","article-title":"DNA transfection: calcium phosphate method","volume":"1018","author":"Kwon","year":"2013","journal-title":"Methods Mol. Biol."}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679026000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679026000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:42:22Z","timestamp":1782531742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679026000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S2666679026000030"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2026.200339","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV18E6 and CDK5 virus-host interaction is a prospective therapeutic target for HPV-positive cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2026.200339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200339"}}